HCAT · Insider trading · 13F holders · Congress trades
Health Catalyst, Inc. (HCAT)
Who is buying and selling HCAT: company insiders on SEC Form 4, hedge funds and superinvestors on Form 13F, and members of Congress under the STOCK Act. Every figure links to the filing or page it comes from.
- 13F filers holding
- 8
- Insider buys, 90 days
- $105K
- Insider sales, 90 days
- $0
- Congress trades, 12 months
- 0
HCAT at a glance
- Between Aug 1, 2026 and Oct 29, 2026, 1 HCAT insider filed 1 open-market purchase worth $105K on SEC Form 4.
- 8 13F filers hold HCAT among their 50 largest positions, worth $58.3M combined. The biggest bets by portfolio weight are CDC Financial, Inc. (10.8%), Palogic Value Management, L.P. (3.5%) and Nepsis Inc. (1.6%). In their latest 13Fs, 0 managers opened a new position and 3 added to one.
- No member of Congress has disclosed a trade in HCAT.
- HCAT last closed at $1.79 on Oct 29, 2026.
HCAT insider trading
Between Aug 1, 2026 and Oct 29, 2026, 1 HCAT insider filed 1 open-market purchase worth $105K on SEC Form 4.
| Filed | Insider | Role | Trade | Shares | Price | Value | Form 4 |
|---|---|---|---|---|---|---|---|
| Sep 16, 2026 | Kohl Simeon | Chief Executive Officer, Director | Buy | 59,000 | $1.79 | $105K | SEC |
Who owns HCAT? Hedge funds and superinvestors
8 13F filers hold HCAT among their 50 largest positions, worth $58.3M combined. The biggest bets by portfolio weight are CDC Financial, Inc. (10.8%), Palogic Value Management, L.P. (3.5%) and Nepsis Inc. (1.6%). In their latest 13Fs, 0 managers opened a new position and 3 added to one.
| Manager | % of portfolio | Value | Shares | Last quarter | 13F |
|---|---|---|---|---|---|
| First Light Asset Management, LLCHedge fund | 1.6% | $25.5M | 12,810,861 | -0.5% shares | Q2 2026 |
| CDC Financial, Inc.Investment manager | 10.8% | $14.1M | 7,092,698 | +12.5% shares | Q2 2026 |
| Palogic Value Management, L.P.Wealth manager | 3.5% | $9.8M | 4,922,442 | +69.9% shares | Q2 2026 |
| Nepsis Inc.Wealth manager | 1.6% | $5.2M | 2,989,705 | +0.5% shares | Q3 2026 |
| HighMark Wealth Management LLCWealth manager | 0.6% | $1.7M | 871,082 | -3.5% shares | Q2 2026 |
| Mink Brook Asset Management LLCHedge fund | 0.6% | $1.5M | 738,277 | — | Q2 2026 |
| Whetstone Capital Advisors, LLCHedge fund | 0.1% | $333K | 167,097 | -96.1% shares | Q2 2026 |
| Veradace Capital Management LLCHedge fund | 0.1% | $139K | 70,000 | +40.0% shares | Q2 2026 |
Each manager counts with its latest 13F (Q3 2026: 1, Q2 2026: 7). Screen HCAT in the grand portfolio →
HCAT stock trades by members of Congress
No member of Congress has disclosed a trade in HCAT.
HCAT questions and answers
Are insiders buying HCAT stock?
Between Aug 1, 2026 and Oct 29, 2026, 1 HCAT insider filed 1 open-market purchase worth $105K on SEC Form 4.
Which hedge funds own HCAT?
8 13F filers hold HCAT among their 50 largest positions, worth $58.3M combined. The biggest bets by portfolio weight are CDC Financial, Inc. (10.8%), Palogic Value Management, L.P. (3.5%) and Nepsis Inc. (1.6%). In their latest 13Fs, 0 managers opened a new position and 3 added to one.
Has Congress traded HCAT?
No member of Congress has disclosed a trade in HCAT.
Who is the largest holder of HCAT?
Among 13F filers, First Light Asset Management, LLC reports the largest HCAT position, $25.5M (12,810,861 shares) in its Q2 2026 13F. The biggest bet by portfolio weight is CDC Financial, Inc.'s: 10.8% of its portfolio.
Cite or share this
Free to use with a link back. The data updates every filing day.